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The spectrum of coronary artery disease among Black African patients in 
South Africa is not completely known. Previous reports have described acute 
coronary syndrome (ACS) in Blacks as uncommon. Studies have shown that 
Blacks have milder coronary artery disease compared to other population 
groups. More recently, reports are showing a rising number of cardiovascular 
risk factors and myocardial infarction in this population group. There is 
currently a paucity of local data looking at the growing burden of this disease 
and the spectrum of presentation in Black African populations. 
 
The aim of this study was to describe the spectrum of coronary artery disease 
in Blacks and determine if there were significant differences in severity and 
outcome as compared to more usually affected population groups with 
coronary artery disease. 
 
A retrospective chart review of Black African patients with acute coronary 
syndrome was conducted at Grey’s Hospital, with data obtained over a twenty 
month period at our tertiary referral centre. Blacks were compared with an 
equivalent number of Indian and Caucasian subjects presenting with acute 
coronary syndrome during the same period. The clinical presentation, 
biochemistry and angiographic findings were examined.  
 
The prevalence of acute coronary syndrome in Blacks was similar to 
Caucasians (17% v. 19%) but lower than Indians (64%). Except for family 
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history (5%), traditional risk factors occurred as frequently in Blacks as in 
Indians and Caucasians. The prevalence of diabetes mellitus in Blacks 
(46.8%) was almost identical to Indians (50%). Hypertension (67%) was 
similar to Indians and Caucasians, but dyslipidaemia (56%) and smoking 
(41%) was lower among Blacks. Metabolic syndrome occurred as frequently 
in Blacks as in Indians.  Black African patients had comparable coronary 
vessel involvement to Caucasians (single and double vessel disease), but 
less three vessel disease (18%). They were more likely to present, ab initio, at 
a younger age compared to Caucasians, with less preceding angina and with 
anterior ST segment elevation myocardial infarction. 
 
In conclusion, the study shows that Black African patients have become a 
high risk group with coronary artery disease than previously thought. It shows 
that coronary artery disease in Blacks is no longer an uncommon problem and 
that they should be considered a high risk group of patients with a 
cardiovascular risk that is comparable to Indians and Caucasians. Aggressive 
screening and treatment of cardiovascular risk factors should be undertaken 





Chapter 1: Background and Literature 
 
Coronary artery disease (CAD) remains the leading cause of cardiovascular-
related mortality worldwide [1]. An extensive review of world literature in 2003 
by Okrainec et al, looked at the burden of coronary artery disease in terms of 
both coronary artery disease mortality and prevalence of risk factors for 
coronary artery disease in developing countries. Significant risk factors for 
coronary artery disease included diabetes, hypertension, Western-type diets 
and smoking. They found that there was a notable paucity of data about the 
prevalence of risk factors in the developing world, including Africa. They cited 
poor financial support, lack of trained medical personnel to identify deaths due 
to coronary artery disease and lack of facilities for invasive procedures such 
as cardiac catheterization, as the main reasons for poor data collection in 
developing countries. Furthermore, they projected an alarming increase in the 
number of cases of coronary artery disease in developing countries, as 
urbanization and exposure to major risk factors, including a Westernized diet 
rich in refined sugars and fats, become more entrenched in societies 
undergoing what they termed “epidemiologic transition.” They projected 
coronary artery disease mortality rates to double from 1990 to 2020, with 
about 82% of that increase occurring in developing countries. In Africa alone, 
their literature search suggested that less than 1% of the African population 
was accounted for within cause-of-death statistics, in contrast to 94% 
registered by the World Health Organization for European countries. This 
suggests that the prevalence of coronary artery disease in developing 
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countries may be highly underestimated. The authors warned of an impending 
epidemic if prevention and targeted control of patient risk factors were not 
implemented.   
 
In contrast, aggressive screening drives and lowering of traditional risk factors 
in Western countries have resulted in declining rates of deaths from coronary 
artery disease in these countries with little variation in the profile of coronary 
artery disease across racial groups [1]. In an American retrospective chart 
review conducted in 2002, Whittle et al looked at the extent of coronary artery 
disease in Blacks compared to Caucasian patients with acute coronary 
syndromes, who underwent coronary angiography during the same 
admission. They found that Blacks were more likely than Caucasians to have 
no significant coronary obstructions. However, there were no racial 
differences in the severity of coronary artery disease among patients with at 
least one significant obstruction [2]. Furthermore, racial differences in 
coronary obstructions remained after correcting for coronary artery disease 
risk factors and characteristics of the acute myocardial infarction [2]. The 
authors concluded that Black patients who presented with acute coronary 
insufficiency, were less likely than Caucasians to have significant coronary 
obstruction. However, they were not able to provide an explanation for this 
apparent difference and indeed, more favourable prognostic factor of coronary 
artery disease in Black subjects [2].   
 
Recently, in the landmark American REACH study published in 2011, 
strikingly higher rates of cardiovascular mortality, related to athero-thrombotic 
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disease were found in Black patients when compared to their Asian, 
Caucasian and Hispanic counterparts [3]. The study showed that although 
medical therapies reduced cardiovascular risk uniformly in all ethnic groups, 
the risk factor profile of Blacks and two year death rate from cardiovascular 
causes were significantly higher [3].  
 
 
GRAPHICAL DEPICTION OF HIGHER RATES OF CARDIOVASCULAR RISK FACTORS 





Fig 1. Under-treatment of risk factors among patients with atherothrombotic disease 
in the Reduction of Atherothrombosis for Continued Health (REACH) Registry by 
ethnicity. SI conversion factor: To convert cholesterol value to mmol/L, multiply by 
0.0259. Mayo Clin Proc. 2011 October; 86(10): 960–967.  
 
It is becoming increasingly apparent that developing countries are in the 
process of ‘epidemiologic transition [4]. Data looking at the prevalence and 
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severity of coronary artery disease among South African Blacks is also 
limited.  Early case reports from the 1960’s and 1970’s reflect the low 
prevalence of coronary artery disease and myocardial infarction in Black 
African patients during those decades. In 1963, Seftel et al looked at the 
characteristics of  Black African patients who had suffered myocardial 
infarction and found a significant correlation between diet, socio-economic 
status and the finding of atherosclerosis at necropsy [5]. They found that of 
the fifteen subjects (out of a total of thirty) who had undergone autopsy, only 
six had features of atherosclerotic disease (three had a mix of superimposed 
thrombus and early atherosclerosis). Furthermore, the six subjects with 
established atherosclerotic disease had a higher prevalence of 
hyperlipidaemia and sedentary lifestyle, in addition to an affluent diet high in 
animal protein and fat. The other six subjects who had demised following 
myocardial infarction had predominantly occlusive thrombus at autopsy and 
were from rural areas, were more active physically and had less animal 
protein and fat -containing diets. While this was a small study with very few 
subjects, it still highlights that nearly half of all Black African patients in the 
study did not have established atherosclerosis [5].In another autopsy study of 
African diabetic patients conducted thirty years ago, no atheromatous 
coronary artery disease was found [6]. 
 
Thandroyen et al, in their 1980 study, showed that hypercholesterolaemia, 
hypertriglyceridaemia and diabetes were associated with coronary artery 
disease in the Caucasian and Indian groups at rates roughly equivalent to 
those reported in the literature, but only hypercholesterolaemia was found to 
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any significant degree in Blacks [7]. Furthermore, hypercholesterolaemia did 
not correlate with coronary artery disease severity in the Black group of only 
seventeen patients [7]. Coronary artery disease was most prevalent in 
Caucasians and Indians, with Blacks having the lowest prevalence of 
coronary artery disease. None of the Black subjects in that study had diabetes 
mellitus, possibly reflecting the very low prevalence of this risk factor for 
coronary artery disease among Black African patients at that time [7]. The 
authors concluded that despite the unequivocal demonstration of coronary 
artery disease in 82% of the seventeen Black African patients, neither 
hypertriglyceridaemia nor hyperglycaemia appeared to be a significant risk 
factor, and that hypercholesterolaemia was important in only 50% of the 
cases. In their abstract, Cassim and Naidoo looked at the profile of African 
patients with myocardial infarction in Durban over a five year period (1991-
1995). They found that myocardial infarction in Africans constituted a 
relatively small percentage of total patients with myocardial infarction (only 
7.4%) [8]. An earlier study conducted in 1991 by Seedat et al reported even 
lower rates of coronary artery disease among Blacks in Durban at 2.4% [9]. 
 
More recently, increasingly severe risk factor profiles for coronary artery 
disease in Black populations have been described. Vezi and Naidoo, in their 
2005 cross-sectional study, showed that Black African patients with Type 2 
diabetes had a higher likelihood of diabetic dyslipidaemia (DD) that involved 
all major subclasses of cholesterol and triglyceride, unlike the “typical” low 
high density lipoprotein cholesterol and high triglyceride reported in other 
ethnic groups with DD [10].  
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Conversely, other studies have suggested a milder form of dyslipidaemia thus 
conferring a favourable prognostic factor and therefore lower prevalence of 
coronary artery disease in Black populations: As put forth by Kalk and Joffe, 
Black African patients with Type 2 diabetes were found to have lower total 
cholesterol levels and lower TG:HDL-C levels (marker of insulin resistance) 
than their Caucasian diabetic counterparts. They concluded that this 
contributed to the lower prevalence of coronary artery disease in diabetic 
Africans [11] , a finding not dissimilar to Naidoo and Cassim in their earlier 
South African study, which found overall lower rates of hypercholesterolaemia 
among Black African patients with myocardial infarction. Indeed, Naidoo and 
Cassim showed, in contrast to Vezi et al 2005, that hypercholesterolaemia did 
not appear to be a significant risk factor for Black African patients with 
myocardial infarction [8]. The lower prevalence of dyslipidaemia among Black 
subjects was also demonstrated by Thandroyen et al in their 1980 study [7]. 
 
The global rise in the clustering of risk factors for coronary artery disease has 
been described previously. The landmark INTERHEART trial analysed 14 
international clinical studies of patients presenting with acute coronary 
syndrome,  [12]. The study showed  that 85% of patients with acute coronary 
syndrome had at least one conventional risk factor [12]. The most recent 
study to date,  showing a similarly disturbing trend, published in October 
2014, was the Mexican study by Gonzalez-Pacheco et al [13]. They looked at 
the clustering of risk factors among patients with acute coronary syndrome 
and significant coronary artery disease confirmed during angiography.  In their 
sample of over 3000 patients with angiographically proven coronary artery 
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disease, they found an alarmingly high prevalence of conventional  risk 
factors in these patients with a male predominance where STEMI was the 
commonest ACS. They found that 95.7% of all patients in the study had at 
least one risk factor for acute coronary syndrome and significant coronary 
artery disease, the highest number ever reported in patients with acute 
coronary syndrome [13]. In their study, smoking and hypertension were the 
most frequent risk factors. What was indeed notable  was the finding of a high 
prevalence of dyslipidaemia with low HDL-C being the commonest lipid 
abnormality [13].   
 
The increasing burden of the metabolic syndrome, diabetes and hypertension 
in South African Blacks, was demonstrated by Ntyintyane et al, who showed 
that 60% of Black African  patients with established coronary artery disease 
had  metabolic syndrome. Waist circumference, hypertension and elevated 
glucose was the most frequent risk factor combination [15] reflecting an 
increase in the  prevalence of clustering of risk factors in patients with 
significant coronary artery disease. The findings in these studies reflecting the 
ever increasing burden of the metabolic syndrome merits further study in our 
local population. 
 
The 2001 NCEP guidelines outline the five diagnostic criteria for metabolic 
syndrome [14]. A finding of three or more criteria are required for a diagnosis 
of metabolic syndrome to be made. They are: 
1. Central Obesity: waist circumference >/= 102cm (40 inches) for males and 
>/= 88cm (36 inches) for females 
 9 
2. Triglycerides (TG): >/= 1.7 mmol/L 
3. High density lipoprotein cholesterol (HDL-C) <1.03mmol/L (males), <1.29 
mmol/L (females) 
4. Blood Pressure: >/= 130/85mmHg 
5. Fasting plasma glucose: >/= 6.1 mmol/L 
 
As informative as these studies are, they are few, with data showing 
conflicting results on the overall outcomes of coronary artery disease in Black 
African patients. Also, local studies tackling the issue are sparse and further 
investigations looking at the spectrum and outcomes of coronary artery 
disease in South African Blacks are needed. 
 
Rationale for this study 
 
Such findings of the increasing burden of cardiovascular risk factors, warn of 
the ever changing spectrum of coronary artery disease in Blacks and makes 
ongoing studies highly relevant for future preventive measures to curb the rise 
of these diseases of “westernization.” Such conflicting data became the 
driving force behind this study, which aimed to establish whether the severity 
of coronary artery disease among our local Black population reflected current 
local and international data. 
 
The spectrum of chronic, non - communicable diseases is clearly changing 
amongst Blacks with an increasing prevalence of metabolic syndrome, 
diabetes, hypertension and dyslipidaemia [15]. There is however, still the 
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perception that coronary artery disease is uncommon in Black subjects. Yet, 
we have observed an increasing number of Black African patients presenting 
to Grey’s Hospital with myocardial infarction. This study was performed to 
raise awareness of the presence of coronary artery disease in Blacks and to 
show that the spectrum of coronary artery disease in this population group is 
changing rapidly, calling for urgent population measures in disease 
prevention.   
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Chapter 2: Aims and Objectives 
 
2.1 Aim of the Study 
 
The aim of this study was to describe the spectrum of coronary artery disease 
in Black African patients referred with myocardial infarction to a tertiary level, 
referral centre i.e. Grey’s Hospital in Pietermaritzburg, which provides regional 
services to both the Umgungundlovu district with an approximate population 
of 1 million people and five surrounding health districts with a population of 
3.5 million people. Grey’s hospital is a public facility that serves the lower to 
middle income group. The aim was to then compare these patients in the 
study group to Indian and Caucasian patients with myocardial infarction. 
 
2.2 Specific Objectives 
 
A retrospective chart review of all Black African patients who were referred to 
Grey’s Hospital (a tertiary level centre in Pietermaritzburg) with myocardial 
infarction over a 20 month period was performed in order to: 
 
2.2.1 Objective 1: 
 
Describe the risk factor profile of these patients 
  
 12 
2.2.2 Objective 2 
 
Determine the site and extent of myocardial infarction (based on ECG and 
enzyme markers) 
 
2.2.3 Objective 3: 
 
Describe the spectrum of coronary vessel involvement at angiography  
 
2.2.4 Objective 4:  
 
Determine the immediate outcome at thirty days in Black subjects as 
compared to gender and age-matched Indian and Caucasian patients referred 
with myocardial infarction during the same period 
 
2.2.5 Objective 5: 
 
Describe the prevalence of metabolic syndrome among Black African patients 
presenting with myocardial infarction 
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Chapter 3: Materials and Methodology 
 
3.1 Study Design 
 
The study was retrospective with a case control design, comparing variables 
related to coronary artery disease between Black, Indian and Caucasian 
groups, with Black African patients forming the study group and Indian and 
Caucasian patients used for comparison. 
 
3.2 Patient Selection 
 
Race was defined on admission when subjects were admitted to hospital. 
Patients were classified according to race as Black African, Indian, Caucasian 
or Coloured. Most Black subjects in the province of Kwa-Zulu Natal are of 
Zulu extraction. The term acute coronary syndrome as outlined by Braunwald 
et al encompasses unstable angina, non ST-segment elevation [non-Q wave] 
MI [NSTEMI], and ST-segment elevation [Q wave] MI [STEMI] [16].  Every 
Black African patient presenting with acute coronary syndrome during the 
study period was selected. A subset of Indian and Caucasian patients, 
matched as closely as possible, within five years for age and gender, were 
consecutively assigned to separate comparative groups. The first Indian and 
Caucasian patient of the same age and gender to present with myocardial 
infarction in the study period, was consecutively selected for comparison with 
the Black African patient presenting with myocardial infarction at the same 
time during the study period. 
 14 
3.2.1 Inclusion Criteria 
 
Only subjects with a diagnosis of acute coronary syndrome who subsequently 
underwent coronary angiography at Grey’s Hospital were included in the 
study. 
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undergo coronary angiography 
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All Black African patients with 
ACS assigned to study group 
Sub-set of Indian and Caucasian 
patients with ACS matched for 







3.2.2 Exclusion Criteria 
 
There were 11 patients with acute coronary syndrome who did not undergo 
coronary angiography and they were excluded. Patients who underwent 
coronary angiography where the primary indication was not acute coronary 
syndrome e.g. screening angiography prior to valve replacement or prior to 
pacemaker insertion, were also excluded. There were seven patients with 
irretrievable files who were also excluded (one Black African, three Indians 
and three Caucasians). 
 
3.3 Data Collection  
 
A retrospective chart review was conducted at Grey’s Hospital in 
Pietermaritzburg. Data was collected spanning a twenty month period from 1 
January 2011 up to 31 August 2012. (Figure 2). We collected the charts of all 
Black subjects diagnosed with acute coronary syndrome for the period 1 
January 2011 to 31 August 2012 and compared them to other race groups, 
i.e. Indians and Caucasians. Demographic data like age and gender, as well 
as proven risk factors for coronary artery disease such as diabetes, 
hypertension, dyslipidaemia, family history of coronary artery disease and 
smoking, were collected from the files.The policy in this unit is to perform 
fasting blood glucose and lipid profiles on all subjects prior to undergoing 
coronary angiography. For the purposes of comparison with previous local 
studies, cut-offs for hypercholesterolaemia were taken as a total cholesterol>5 
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[8]and LDL > 2.5[17]. Dyslipidaemia included a triglyceride level of >/=1.7, 
HDL-C<1.29 in females and <1.03 in males [18].  
Data was also collected in order to screen for metabolic syndrome among the 
patients selected for study. As outlined by the NCEP from 2001 [14], a person 
would be considered to have metabolic syndrome if at least three of the 
following criteria are met: 
 
1. Central obesity: waist circumference >/= 102 cm (40 inches) (for males) 
and >/=88cm (36 inches) (in females) 
2. Triglycerides: >/= 1.7 mmol/L 
3. High-density lipoprotein cholesterol (HDL-C) < 1.03 mmol/L in males, <1.29 
mmol/L in females 
4. Blood pressure: >/= 130/85 mmHg 
5. Fasting plasma glucose: >/= 6.1 mmol/L 
 
Furthermore, clinical characteristics were collected. The initial presentation 
described whether patients presented to their referring hospital with acute 
chest pain i.e. chest pain experienced for the first time, a change in character 
of their existing, chronic angina, or with other symptoms like syncope. 
Biochemical parameters including cardiac enzymes, renal function and 
haemoglobin were also collected. In addition to these laboratory parameters, 
changes on the electrocardiogram were described. Angiographic findings 
describing the site and extent of myocardial infarction were also extracted 
from the files. In addition, outcomes were determined on the basis of a new 
myocardial infarction after the index myocardial infarction, the number of 
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months until a new myocardial infarction, functional status of the patient 
following myocardial infarction and employment status post-myocardial 
infarction. A functional status questionnaire was presented to patients 
telephonically and looked for suggestive symptoms of heart failure like lower 
limb oedema, orthopnoea and paroxysmal nocturnal dyspnoea and whether 
or not these patients suffered from chronic angina, or had complete resolution 
of symptoms following the myocardial infarction. Information pertaining to the 
abovementioned outcomes was obtained telephonically one year after the 
study period. Parameters were entered onto EXCEL spreadsheets for 
comparison of the Black group with Indian and Caucasian groups. 
 
3.4 Ethical Considerations 
 
Full ethical approval was obtained from BREC prior to commencement of the 
study (BREC Number: BE299/12 ). The names of patients selected for study 
were encoded in numerical sequence to preserve confidentiality. Telephonic 
consent was obtained from each patient during the follow-up part of the study 
before any questions were asked. 
 
3.5 Statistical methods and analysis 
 
Data was entered into SPSS version 21 (Statistical Packages for the Social 
Sciences) for analysis. Data analysis was initiated with a check of the data for 
outliers, missing data, and normality through skewness and kurtotis values 
that could affect relations between variables. A descriptive statistical analysis 
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of the data (means, standard deviations, ranges, frequencies and 
percentages) was initially conducted prior to computing the inferential 
statistics. One way analysis of variance (ANOVA) between groups was used 
to compare means differences of single normally distributed interval 
dependent variables (e.g. age) by selected categorical variables e.g. race, 
gender etc. A factorial ANOVA was used for two or more categorical 
independent variables (either with or without the interactions). If the selected 
covariate was not normally distributed (base on the Shapiro-Wilk test) then a 
non-parametric equivalent, namely the Kruskal-Wallis equality-of-populations 
rank test, was used instead. A Pearson chi-squared (χ2) test was used to 
assess significant differences in proportions of categorical cross tabulations. If 
the expected cell count in any cross tabulation was less than 5, then a non-
parametric Fishers exact test was used. Logistic regression was used to 
compare clinical and other characteristics by Black ethnicity versus Indian and 
Caucasians combined. Coefficients were exponentiated to represent odds 
ratios with 95% confidence intervals (CI’s). Adjustment for multiple testing 
using the Simes method was also used. A p-value <0.05 was considered as 
statistically significant for all tests. 
  
 19 
Chapter 4: Results 
 
4.1 Prevalence of acute coronary syndrome 
 
During the study period, we identified 469 patients who were admitted to 
Grey’s Hospital with acute coronary syndrome (UA, NSTEMI and STEMI), 458 
of whom underwent coronary angiography. Eleven patients did not undergo 
angiography and were excluded. 
 
A total number of 481 angiograms were performed during the study period. 
There were 16patients who underwent angiography for which the primary 
indication was not acute coronary syndrome (screening pre-valve 
repair/during pacemaker insertion). Files were not found in seven patients and 
it was unclear whether myocardial infarction was the primary indication for 
angiography. All these patients were thus excluded leaving four hundred and 
fifty eight subjects with acute coronary syndrome for analysis. (Figure 3) 
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Total of 469 patients admitted 
with ACS during the study period 
481 angiograms performed over 
the study period 
11  patients did not undergo 
angiography excluded 
458 cases of ACS left  for 
analysis 
16 patients without ACS 
underwent angiography 
7 patients underwent 
angiography: unclear indication 
Total of 79 Blacks with ACS 
Total of 86 Caucasians with ACS 
Total of 293 Indians with ACS 
79 Black assigned to 
study group 
Subset of 80 Caucasians 
assigned to control group 
Sub-set of 79 Indians 
assigned to control group 
 




Fig. 4. Number of ACS over 20 months. The highest proportion of MI was among 
Indian patients. Number of MI in Blacks and Caucasians was similar. 
 
 
There were 79 Blacks (17.24%), 293 Indians (64%) and 86 Caucasian 
patients (19%) with acute coronary syndrome, yielding an in-hospital 
prevalence of ACS in Black subjects of 17.24% of the total number of patients 
with ACS over the study period. (Figure 4). All of the 79 cases of acute 
coronary syndrome among Black African patients were assigned to a study 
group. A subset of 79 Indians and 80 Caucasians from the total number, 




4.2 Demographic data 
 
By design, Blacks, Caucasians and Indians comprised three equal groups. 
The demographic data are summarised in Table 1 below. Median age 
amongst Blacks and Indians was similar by design but tended to be 










efforts to match them for age. The mean age of all males and females in the 
three groups was not significantly different (56.0 v. 57.8, p = 0.295). Males 
comprised 65.8% of patients in the Black group. Within the Black group, 
females were significantly older than males (58.8 v. 52.8, p = 0.033). 
 
 Table 1. Baseline characteristics of the study population 
 
 
*: t-test; ┼: Wilcoxon rank=sum test; ╪: Chi-squared (χ2) test; §: Fishers exact test 
¶: Smoking pack year data only collected from 24/32 Black smokers, 31/51 Indian Smokers 
and 35/50 Caucasian smokers. 
║: Interquartile range  
 
 
There is a high prevalence of exposure to selected risk factors across all the 
racial groups. There was no significant difference in the prevalence of 
diabetes and hypertension across the groups (p = 0.230 and p = 0.491 
respectively). Dyslipidaemia and smoking was significantly lower in the Black 
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4.3 Risk factor profiles 
 
In the group of two hundred and thirty eight subjects selected for study, 45.0% 
had diabetes, 65.1% had hypertension and 73.5% had dyslipidaemia. A family 
history of CAD was present in 37.8% and 55.9% of the group were smokers. 
The smoking prevalence was lowest in the Black group, and highest in the 
Indian and Caucasian groups (40.5% v. 64.6% v. 62.5%; p = 0.004). 
 
The prevalence of diabetes among Blacks, Indians and Caucasians was 
similar with no significant difference between the groups (46.8% v. 50.6% v. 
37.5%; p = 0.230). Similarly, there was no significant difference in the 
prevalence of hypertension (67.1% v. 68.4% v. 60.0%; p = 0.491) between the 
groups. Blacks had the lowest proportion of dyslipidaemia (56.4% v. 79.5% v. 
87.3%; p <0.001) compared to Indians and Caucasians. Table 2 shows that 
hypercholesterolaemia was significantly different by race with the lowest 
prevalence in the Black group (14.3% v. 25% v. 41.4%; p = 0.003) compared 
to the Indian and Caucasian groups. Blacks had a marginally significantly 
lower total cholesterol compared to Indians and Caucasians(see Table 3); 
(4.0 v. 4.5 v. 4.6; p = 0.017). Blacks also had significantly lower LDL levels 
compared to Indians and Caucasians (2.2 v. 2.9 v. 2.9; p = 0.004). 
Hypertriglyceridaemia was not significantly different in Blacks compared to 
Indians and Caucasians (37.1% v. 50.8 v. 38.2%; p = 0.209). Blacks had 
marginally comparable rates of atherogenic dyslipidaemia to Indians and 
Caucasians (31.9% v. 44.6% v. 25.8%; p = 0.067). Of significance however is 
the median HDL-C was identical for all three groups at 0.9 mmol/L. Blacks 
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had the lowest prevalence of family history of coronary artery disease 
compared to Indians and Caucasians (5.1% v. 65.1% v. 42.5%; p  < 0.001). 
 




N = 70 
Indian 
N = 65 
Caucasian 
N = 68 
Total  
N = 203 
p-value٭ 
Triglycerides (TG) >/= 1.7  
n (%) 
 
HDL-C < 1.29 (females)  
n (%) 
 
HDL-C< 1.03 (males)  
n (%) 
 












































































































































































































 Kruskal Wallis test; ┼: Adjusted for multiple test comparisons using the Simes method; ╪: Number of :٭
non-missing observations: Black, Indian, Caucasian=  71, 65, 70; §: Number of non-missing 
observations: Black, Indian, Caucasian=  63, 58, 56;  ¶: Number of non-missing observations: Black, 
Indian, Caucasian =  70, 65, 68; ║: Number of non-missing observations: Black, Indian, Caucasian=  69, 
65, 67 
 
4.4 Clinical data 
 
The major aspects of the clinical presentation that were examined are 
summarised in  Table4. Significantly more Blacks presented with new-onset 
chest pain (OR = 2.61; p= 0.003) and sweating (OR = 2.68; p= 0.010) as the 
initial symptom, and were significantly less likely to present with worsening of 
chronic angina compared to Indians and Caucasians (OR = 0.31; p< 0.001). 
Blacks were significantly more likely to present with a first acute coronary 
syndrome compared to Indians and Caucasians(88.6% v. 58.2% v. 63.8%; 
OR = 4.80; p< 0.001). 
 
STEMI was the most common acute coronary syndrome in the Black group 
(57% v. 38% v. 35%; OR = 3.74; p< 0.001) compared to Indians and 
Caucasians. 
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Unstable angina was significantly lower among Black African patients 
compared to Indians and Caucasians(15.2% v. 43% v. 35%; OR = 0.26; p< 
0.001). NSTEMI prevalence did not significantly vary by race (26.6% v. 19.0% 
v. 28.8%; OR = 1.21; p = 0.543). 
 
Anterior and apical myocardial infarction were the commonest sites of 
infarction in the Black group compared to Indians and Caucasians (45.6% v. 
35.1% v. 26.3%; OR = 1.87; p= 0.032 for anterior, 27.6% v. 13.3% v. 15.6%;  
OR = 2.09; p= 0.037 for apical). Left ventricular ejection fraction was similar in 
all three groups (mean: 48.6% [95% CI: 47.1-50.1]; p = 0.372). There were no 
significant differences in the risk of complications between the groups. 
 
Table 4. Clinical Characteristics of the study population  
 
Characteristic: n (%) Black 
N = 79 
Indian 
N = 79 
Caucasian 
N = 80 
Total  




Symptoms       










Acute on chronic pain 15 (19) 35 
(44.3) 
31 (38.8) 81 (34) 0.31 [0.16- 
0.61] 
0.001 





4 (5.1) 6 (7.5) 20 (8.4) 2.13 [0.83- 
5.50] 
0.117 





5 (6.3) 11 (13.8) 34 (14.3) 2.68 [1.30- 
5.65] 
0.010 
Nausea/vomiting 9 (11.4) 3 (3.8) 3 (3.8) 15 (6.3) 3.40 [1.13- 
10.1] 
0.029 
Heart failure/ Dyspnoea 2 (2.5) 4 (5.1) 2 (2.5) 8 (3.4) 0.62 [0.12- 
3.30] 
0.573 
Event type       









NSTEMI 21 15 (19) 23 (28.8) 59 (24.8) 1.21[0.65- 0.543 
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(26.6) 2.28] 





Unstable angina 12 
(15.2) 
34 (43) 28 (35) 74 (31.1) 0.26 [0.13-
0.53] 
<0.001 
New LBBB 1 (1.3) 0 (0) 1 (1.3) 2 (0.8)     1.77 [0.12-
29.31] 
0.69 
ECG       























12 (15) 40 (16.8) 0.72 [0.33-
1.53] 
0.388 
Posterior 2 (2.6) 2 (2.6) 2 (2.5) 6 (2.5) 0.87 [0.15-
4.98] 
0.879 
RV infarct 3 (3.8) 1 (1.3) 0 (0) 4 (1.7) 5.33 [0.53-
53.27] 
0.154 
No new ischaemic changes 
on ECG 
7 (9) 17 
(22.1) 
18 (22.5) 42 (17.6) 0.34 [0.14-
0.81] 
0.015 
Angiographic findings╪       
Infarct site       




14 (26.3) 66 (27.7) 2.06 [1.07-
3.98] 
0.031 
- Inferior 4 (6.9) 7 (11.1) 5 (8.1) 16 (6.7) 0.71 [0.22-
2.31] 
0.569 
- Lateral 30 
(51.7) 
29 (46) 19 (30.6) 78 (32.8) 1.67 [0.88-
3.18] 
0.119 
- Septal 17 
(29.3) 
12 (19) 8 (12.9) 37 (15.5) 2.1 [0.97-
4.37] 
0.059 
- Posterior 11 (19) 15 
(23.8) 
20 (32.3) 46 (19.3) 0.62 [0.29-
1.35] 
0.232 




15 (15.6) 62 (26.1) 2.44 [1.25-
4.76] 
0.009 
- Basal 11 (19) 14 
(22.2) 
18 (29) 43 (18.1) 0.69 [0.32-
1.50] 
0.354 
- No RWMA 11 (19) 24 
(38.1) 
25 (40.3) 60 (25.2) 0.36 [0.17-
0.77] 
0.008 
- Global hypokinesis 4 (6.9) 0 (0) 1 (1.6) 5 (2.1) 10.85 [1.13-
104.30] 
0.039 














64 (80) 193 (91) 1.36 [0.64-
2.88] 
0.424 
Ventricular tachycardia 5(6.3) 2 (2.5) 12 (15) 18 (7.6) 0.79 [0.27-  
2.34] 
0.673 
Complete heart block 2 (2.5) 3 (3.8) 0 (0) 5 (2.1) 1.61 [0.25-    
10.5] 
0.617      








 logistic regressions adjusted for age and gender; ┼: zero events in Black ethnicity; ╪: Number of non-missing :٭
observations: Black, Indian, Caucasian = 61, 61, 61; §: Number of non-missing observations: Black, Indian, 
Caucasian = 61, 67, 51 




4.5 Biochemical data 
 
As shown in Table 5, Blacks had significantly higher troponin I levels when 
compared to Indians and Caucasians (5.94 v. 0.85 v. 1.6; p = 0.02). Blacks 
also had significantly lower haemoglobin levels compared to Indians and 
Caucasians(13.05 v. 14.1 v. 14.3; p = 0.010). Renal function was similar 
across all three groups with a normal serum urea (4.25 v. 5.2 v. 5.1; p = 
0.052) and normal serum creatinine (85 v. 85 v. 85; p = 0.782). HbA1C was 
elevated among all three race groups and was not significantly different 
between Blacks, Indians and Caucasians (6.65 v. 6.4 v. 6.3; p = 0.118). This 
is not surprising since the prevalence of diabetes was similar across the 
groups. 
 
Table 5. Biochemical parameters  
 
 
















CKMB fraction [ug/l] ┼ 
 


















































































 :╪ ;Interquartile range; ┼: Number of non-missing observations: Black, Indian, Caucasian = 67, 67, 71 :٭
Number of non-missing observations: Black, Indian, Caucasian=,  76. 73, 74 ; §: Number of non-missing 
observations: Black, Indian, Caucasian =  76, 77, 79; ¶: Number of non-missing observations: Black, 
Indian, Caucasian = 76, 79, 79; ║: Number of non-missing observations: Black, Indian, Caucasian = 76, 
 Number of non-missing observations: Black, Indian, Caucasian = 48, 48, 49; ┼┼: Kruskal :٭٭ ;79 ,79
Wallis test; ╪╪: Adjusted for multiple test comparisons using the Simes method 
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4.6 Angiographic findings 
 
As outlined in Table 6, a significant association exists between the severity of 
coronary vessel involvement and race. Black African patients had a lower 
prevalence of three vessel disease (TVD) compared to Indians and 
Caucasians(17.9% v. 46.2% v. 30.4%; p < 0.001). Blacks were similar to the 
Caucasian group in the number of patients with double vessel disease (DVD) 
(15.4% v. 20.5% v. 15.2%; p < 0.001) and single vessel disease (SVD) 
(32.1% v. 20.5% v. 30.4%; p < 0.001). A significantly higher proportion of 
Blacks with acute coronary syndrome had normal epicardial coronaries 
compared to Indians and Caucasians (23.1% v. 6.4% v. 8.9%; p < 0.001). 
 
Table 6. Angiographic findings 
 
 
Characteristic: n (%) Black 
N = 79 
 
Indian 
N = 79 
Caucasian 
N =  79 
Total  
N = 238 
p-
value٭ 
Left main stem disease 
 
Triple vessel disease 
 
Double vessel disease 
 





















































: Pearson chi-squared (χ2) test; ┼: excluded from test statistic 
 
 
There was significantly less severe involvement of coronary arteries in the Black group (p = 




4.7 One year follow up 
 
Patients were contacted telephonically 1 year after the study period. 
Unfortunately, follow-up at one year was poor. Only 40% of Black African 
patients and 60% of Indians and Caucasians could be contacted (See Table 
7). Recurrent myocardial infarction was more frequently documented in 
Indians followed by Caucasians, than Blacks, but there was no significant 
difference between the groups. There was no significant difference in 
numbers of new myocardial infarction after the index myocardial infarction by 
race (p = 0.364).  Blacks had a significantly lower incidence of recurrent 
angina (p = 0.044) and were marginally significantly more likely to be stable 
one year following myocardial infarction (p = 0.052). No significant difference 
in recurrent heart failure was observed by race (p = 0.122). More Indians had 
undergone or were awaiting coronary artery bypass grafting followed by 
Caucasians than Blacks, but this was also not statistically significant (p = 
0.425). More Indians and Caucasians underwent stent insertion as compared 
to Blacks, though not statistically significant (p = 0.857). Although more 
Indians had died at one year follow up as compared to Blacks and 














Table 7. Follow-up at one year 
 
Characteristic: n (%) Black 
N = 34 
Indian 
N = 53 
Caucasian 











































 ;Chi-squared (χ2) test; ┼: Had already undergone or were awaiting CABG : ٭
╪: Fishers exact test 
 
 
4.8 Estimated minimum prevalence of metabolic syndrome 
 
In order to establish the prevalence of risk factor clustering among the groups, 
we also evaluated the number of patients who presented with three or more 















BP >/= 130/85 
HDL < 1.03 M 
< 1.29 F 
Tg>/= 1.7 
2 MS criteria 
3 MS criteria 
Blacks 




































For the purposes of this analysis, metabolic syndrome was diagnosed 
according to the NCEP criteria [14]. For most subjects however, there was no 
data on waist circumference. Thus, our statistics presented on the metabolic 
syndrome in all likelihood underestimated the true prevalence. Based on any 
three criteria the minimum prevalence of metabolic syndrome was equally 
common in the Black, Indian and Caucasian groups (52% v. 52% v. 59%). 
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Chapter 5: Discussion 
 
This study aimed to describe the changing spectrum of coronary artery 
disease in Blacks and see how it differed when compared to other race 
groups in South Africa. The results show that this spectrum has clearly 
changed with an increase in the prevalence of myocardial infarction in Blacks, 
a finding in agreement with recent studies which showed a strikingly high 
prevalence of risk factors for coronary artery disease in urbanised Black 
subjects [15].Indeed, this study shows that the risk factor profile of myocardial 
infarction in Blacks and Indians is almost identical. 
 
 Blacks matched Caucasians in the number of cases of myocardial infarction, 
constituting 17% of all cases of myocardial infarction referred during the study 
period. This is in stark contrast to Naidoo and Cassim’s 1996 abstract, where 
they estimated the prevalence of Black myocardial infarction to be just under 
8% in their study cohort [8]. Our finding also contrasts with the earlier study by 
Seedat et al, which showed an even lower prevalence of Black myocardial 
infarction (2.4%) in that cohort [9]. 
 
We can explain this finding if we look once more at the Okrainec review article 
[1], which described how developing countries are undergoing rapid 
urbanization and epidemiologic transition, thus exposing larger numbers of 
lower socioeconomic groups to multiple risk factors for coronary artery 
disease despite a lack of affluence. South Africa is a country with both affluent 
and impoverished communities and illustrates this progressive urban 
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transition as more people move to urban areas looking for work and are 
exposed to risk factors for coronary artery disease. Westernization of the 
traditional African diet coupled with increasing rates of obesity and metabolic 
syndrome are likely contributors to this observation. A nutrition transition [1] 
which describes the shift in the global diet from complex carbohydrates and 
fiber to higher proportions of sugars and fats, is likely to be a significant factor 
in explaining the high number of patients with metabolic syndrome and 
coronary artery disease in our study. 
 
There was a strong family history of coronary artery disease amongst Indians 
and Caucasians but only 5% of Blacks had a positive family history of 
coronary artery disease. Early studies describing much lower rates of 
atherosclerotic disease as well as fewer risk factors for coronary artery 
disease in Black African patients have already been discussed [5], [6], [7], [8], 
[9], and highlight how dramatic the change has been over the last three 
decades, as shown in our study and others [15] 
 
Caucasian patients presenting with myocardial infarction tended to be 
significantly older than Black subjects even with attempts to match the two 
groups by age. Previous studies have already reflected that Blacks with 
coronary artery disease were younger than their Caucasian counterparts [11]. 
Our study confirms this, making early screening for coronary artery disease 
an important aspect of primary prevention in this group. Having said this, it is 
possible that younger, more affluent Caucasian patients with myocardial 
infarction, are presenting to private hospitals for treatment and thus the 
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observation that Caucasian patients tended to be significantly older may not 
be an accurate reflection of the general population in Kwa-Zulu Natal and just 
reflects the demography at Grey’s Hospital. More than two thirds of Black 
African patients in the study were male, a finding that is consistent with 
previous reports which have shown that coronary artery disease is three-fold 
higher in males than females, and mortality five-fold higher [19].  
 
What was indeed startling was that the prevalence of traditional risk factors 
among Blacks was similar to Indians and Caucasians. It is known that 
hypertension is a global health burden affecting both developed and 
developing countries, including South Africa [20]. So it is not surprising that 
hypertension was frequently present in two thirds of subjects and affected all 
groups equally. Unexpectedly, Blacks appeared to have as much diabetes 
compared to Indians. This finding is compatible with a recent report by 
Ntyintyane et al. of the increasing burden of diabetes in urbanized Black 
South Africans with CAD [15].These authors found a high prevalence of 
obesity which, coupled with a sedentary lifestyle are likely driving the 
emergence of Type 2 diabetes and thus predisposition to CAD in urbanised 
Black South Africans. It is noteworthy that of the total cohort of two hundred 
and thirty eight study participants, 31 patients (14 Blacks, 5 Indians and 
12Caucasians), i.e. 13% of patients were not screened for diabetes and this 
may have underestimated the prevalence of diabetes in the cohort. Poor 
documentation of diabetic status may have also contributed to this result, 
illustrating some of the challenges of a retrospective study. Indians had the 
highest rates of diabetes and smoking which are proven major risk factors in 
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the progression of atherosclerosis and consistent with previous studies 
showing that smoking decreases HDL-C levels and increases the risk of 
myocardial infarction through long term effects on the atherosclerotic process 
[21].  
 
The finding of a lower prevalence of hypercholesterolaemia and dyslipidaemia 
in Blacks is consistent with previous reports [7], [8], [11]. It is notable however 
that one third of Blacks in our study had atherogenic dyslipidaemia (Table 2). 
Atherogenic dyslipidaemia (low HDL cholesterol and raised triglycerides) is a 
typical feature of obesity, insulin resistance, and Type 2 diabetes, and has 
emerged as an important risk factor for MS and a subsequent predisposition 
to cardiovascular disease [22].  
 
It is also noteworthy that in our study, 95% of Black females and 70% of 
males had low HDL-C levels, in keeping with the presence of metabolic 
syndrome and diabetes, resulting in a predisposition to coronary artery 
disease and MI. Indeed, one in two Black African patients had diabetes, 
explaining the atherogenic lipid profile in these patients. The very high 
prevalence of low HDL-C in our Black subjects with MI suggest that this may 
become an effective screening test in order to identify Black African patients 
with a high risk of coronary artery disease at an earlier stage. This finding is in 
agreement with a recent study in Mexico in which 85.1% of all patients with 
myocardial infarction had some form of dyslipidaemia, with low HDL-C levels 
having the highest prevalence(68.6%) of all the alterations in the lipid profile 
[13].  
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The estimated prevalence of metabolic syndrome in Black African patients 
with myocardial infarction was 20% and was very similar to the Indian group 
(21.5%) in the study. These findings correlate with previous reports of the high 
burden of cardiovascular risk factors and metabolic syndrome in Black African 
patients [15]. However, the lack of documentation of waist circumference in 
patient’s files has also likely underestimated the true prevalence of metabolic 
syndrome in our study (especially as 95% of females had low HDL and nearly 
half of all Black African patients had proven diabetes). Had we measured 
waist circumference in our study, the true prevalence of metabolic syndrome 
may have been closer to the 60% MS prevalence reported in Ntyintyane’s 
2006 study [15] . 
 
The main risk factors that have emerged from our study were diabetes and an 
atherogenic lipid profile – two important components of the metabolic 
syndrome. Our study clearly shows that Black African patients with MI already 
have a high prevalence of metabolic syndrome and other risk factors for CAD 
that is comparable to Indians. 
 
The study also found that Blacks were more likely to present with their first 
myocardial infarction on admission, with anterior ST segment elevation 
myocardial infarction (STEMI) and with first-time chest pain. This suggests 
that Black African patients may not have warning signs like preceding angina 
or an established history of coronary artery disease when they present to 
hospital, which makes aggressive screening programs and control of risk 
factors in this group exceedingly important.  In contrast to the sudden, notably 
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anterior ST segment elevation myocardial infarction in Blacks, the study 
showed that Indians and Caucasians present more frequently with a change 
in character of their chronic angina. Studies have shown better clinical 
outcome in patients with preceding angina with less left ventricular 
remodelling than those with no preceding angina on the basis of ischaemic 
preconditioning [23]. Indian and Caucasian patients had significantly higher 
rates of unstable angina (UA) and non - ST segment elevation myocardial 
infarction (NSTEMI) when compared to Black African patients. They were also 
more likely to present with a second or third myocardial infarction, have a 
background of pre-existing coronary artery disease and were more likely to 
have undergone interventions such as stenting and coronary artery bypass 
grafting. Sweating was an uncommon symptom possibly due to underlying 
diabetic autonomic neuropathy. Blacks however, did present significantly with 
sweating as a concomitant symptom although rates of diabetes in this group 
were similar to controls.  
 
Our results also show that Blacks have a similar spectrum of coronary vessel 
involvement at angiography as Caucasians. Single vessel disease and double 
vessel disease were the commonest findings in these two groups. This 
contrasts with previous reports, where double vessel disease was the 
commonest finding in all three racial groups [7]. Indeed, a significantly higher 
proportion of Black African patients (32.1%) had single vessel disease as 
compared to Indians (20.5%). These findings are in contrast to the 
observations of Whittle et al, whose study showed that Blacks had a higher 
likelihood of non-occlusive disease than Caucasians [2]. Although a higher 
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number of Blacks had normal epicardial coronaries at angiography, our study 
shows a significantly greater severity of coronary vessel involvement in Blacks 
that was comparable to Caucasians. Our study shows a significantly greater 
severity of coronary vessel involvement in Blacks that was comparable to 
Caucasians. Indians had the highest prevalence of three vessel disease, 
which is not surprising considering the high burden of diabetes and coronary 
artery disease in this group [19]. 
 
Eighteen Black subjects with MI had normal coronary angiograms. Of these, 
three had received fibrinolysis, which could have explained these findings. 
The finding of normal epicardial vessels amongst Black MI may reflect 
microvascular ischaemia, spontaneous thrombolysis, occult atherosclerosis or 
some other unexplained phenomenon. In our study, more Blacks underwent 
thrombolysis compared to Indians and Caucasians (35% v. 16.1% v. 
34.4%).Another explanation for the finding of normal coronary vessels could 
be related to angiographic spontaneous reperfusion of the culprit infarct-
related artery, which is a recognised feature of ST-segment elevation 
myocardial infarction and is known to be associated with better clinical 
outcomes in patients [24].  
 
Furthermore, it is known that acute coronary syndromes can frequently occur 
as a result of disruption of modestly stenotic plaques, not detectable by 
angiography, but only by intravascular ultrasound, which may account for the 
higher number of normal coronaries in the Black group and suggests a 
possibly milder form of coronary artery disease in this group [25]. 
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An analysis of previous and current literature shows a clear change in the 
spectrum of coronary artery disease among South African Black patients as 
outlined in Table 9, which shows the gradual increase in the prevalence of 
conventional risk factors for coronary artery disease in Black African patients. 
 
An early study by Seftel et al suggests an already higher prevalence of 
hypercholesterolaemia and diabetes [26]; however there was small number of 
patients in this study. Our findings contrast with Seedat’s study [9] showing a 
low prevalence of hypercholesterolaemia and diabetes as well as with 
Thandroyen’s article [7] in which no cases of diabetes in Black subjects were 
found. Our finding of a 95% prevalence of low HDL-C in females, correlates 
with Ntyintyane’s study [15], which showed that up to 57% of females with MS 
had low HDL levels. Furthermore, our finding of an increased prevalence of 
diabetes is in agreement with Ntyintyane’s 50% prevalence of glucose 
dysregulation. In keeping with the Interheart study [12] our study suggests 
that major risk factors are the driving factors behind the development of MI in 
Black subjects. Diabetes and its associated dyslipidaemia with a low HDL-C 
were the commonest major risk factors in our study. Of importance, our 79 
subjects were collected over a period of 20 months reflecting an increase in 
the incidence of coronary disease in Black subjects over a relatively short 






Table 9. The Changing Spectrum of CAD in South African Blacks 
 
Year Author Black MI Lipid profile Diabetes % 
1970 Seftel et al.[26] N =  24 TC:MI v. Controls:195 v 172mg/100ml 
TG: MI v Controls129 v 68 mg/100ml 
(10/24) 40%  
1980 Thandroyen et al. [7] N = 17 High TC 50% 
High TG-23% 
High TG: No correlation with severity of CAD 
0 
1992 Seedat et al. [9]* N = 458 “Hypercholesterolemia less common” 
TG – 11.2% (males), 3.5% (females) 
“Protective levels of HDL in 81.3%”;  





1995 Cassim, Naidoo [8] N = 104 Hypercholesterolaemia : 40% 10% 
2006 Ntyintyane et al. [15] N = 40 Low HDL: 33% (males), 57% (females) 
Hypercholesterolaemia: not shown 
20%  
30% IGT 
2014 Dela N = 79 TC: 14.3% 
TG: 37.1% 
Low HDL in 95% of  females, 57% of males 
46.8%;  
 
*This study was a community survey as opposed to the other studies which were performed in Black 
subjects with MI. 
 
Outcomes were difficult to assess due to poor follow-up rates in all three 
groups, particularly the Black group.Rather than underreporting this 
information, the authors believe that presenting this data reflects the logistical 
challenges and oftentimes poor documentation at hospitals. The lack of 
follow-up also demonstrates the social and economic challenges in our 
environment. Notable challenges relating to poor follow up included no 
contact details being available, phone numbers often not being given to the 
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admitting nurse as well as expired and incorrect numbers being recorded in 
files. Although not significant, the results at one year follow-up suggest that 
Caucasians had the lowest number of myocardial infarction after the index 
acute coronary syndrome. Indians had the highest rate. Had follow-up been 
better, we could have assessed how Blacks fared in the medium term 
following the initial myocardial infarction. Indians and Caucasians were 
referred for coronary artery bypass grafting more often than Blacks, reflecting 
greater severity of coronary artery disease in the Indian and Caucasian 
groups. Stent insertion also appeared higher in the Indian and Caucasian 
groups, with more Black African patients managed with optimum medical 
treatment. More Indians had died at one year follow-up, but this again needs 
to be proven through larger cohorts and prospective studies. Blacks had the 
lowest incidence of chest pain and heart failure and were more likely to be 
stable one year following myocardial infarction. Although not significant due to 
poor follow-up, these results may reflect a better outcome in Blacks, but 
greater numbers are needed to prove this. It is difficult to comment on return 
to employment although more Caucasians and Indians had returned to work 
after myocardial infarction. 
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OVERSIGHT, LIMITATIONS, CHALLENGES AND RECOMMENDATIONS 
 
Several limitations of this study relate to its retrospective design. The lack of 
data regarding abdominal circumference and body mass index, as well as 
fasting glucose levels and glucose tolerance tests reduced the strength of the 
study and the accuracy of data to diagnose metabolic syndrome and diabetes. 
Had these variables been recorded, they would have provided greater 
information regarding the prevalence of metabolic syndrome in each race 
group. Furthermore, no records were found of waist circumference 
measurements that in all probability, also underestimated the prevalence of 
metabolic syndrome in our study. A diagnosis of hypertension was made 
either based on a previous diagnosis or from the final discharge summary. 
There was no indication as to whether the diagnosis was based on 
established guidelines. 
 
Low follow up rates were a challenge.The initial objective of the study was to 
follow-up patients at 30 days following myocardial infarction, but this even this 
was not possible although the clinic was in a tertiary environment. Home 
visits, confirmation of telephone numbers and more effective communication 
with patients could be beneficial. Most of our patients in the Black group were 
of Zulu extraction with isiZulu being their first language. Communication of 
follow-up plans following discharge from the ward may have been 
compromised if patients were unable to understand, especially if they were 
informed about their follow-up plan in English. Furthermore all discharge 
summaries are typed out in English and this could also have been difficult to 
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understand for the patient possibly accounting for lack of follow-up.   
Emphasis on the need for clinic follow-up must be undertaken and in patients 
with poor socio-economic conditions, who cannot afford transport to hospital, 
improved communication with the referring hospital must be done to prevent 
patients being lost to follow-up and may help solve this problem. 
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Chapter 6: Conclusion 
 
In summary, while CAD remains a common disease among Indians and 
Caucasians, this condition has clearly increased from previous anecdotal 
reports to four per month among Blacks at our institution. The increasing 
incidence of myocardial infarction in Black subjects is clearly attributable to 
the dramatic changes in their risk factor profiles.  
 
Almost one in two Black subjects with myocardial infarction were diabetic and 
almost a third have atherogenic dyslipidaemia. What is alarming is that almost 
all Black females and three quarters of Black men have low HDL-C 
suggesting a greater predisposition to coronary artery disease.  The high 
prevalence of major risk factors, with the exception of a positive family history, 
clearly places them at high risk. Although Blacks still have overall lower rates 
of hypercholesterolaemia and smoking, other traditional risk factors are found 
in similar numbers of Blacks with myocardial infarction compared to Indians 
and Caucasians, especially diabetes and atherogenic dyslipidaemia. The 
prevalence of metabolic syndrome in this group is also rising. The change in 
risk factor profile in the absence of family history suggests that this change 
has happened in the last generation. This is clearly attributable to the rapid 
urbanization of our country since 1994 and calls for urgent primary and 




Blacks had less triple vessel disease at angiography than Indians and they 
were more likely to present at a younger age than Caucasians, with anterior 
ST-segment elevation myocardial infarction, first myocardial infarction, and 
without preceding angina making them a high risk group.  
 
Indeed the high risk factor profile of Black subjects with MI, indicates that it is 
almost too late for primordial prevention measures in this group since these 
risk factors are already established in the urbanised Black population [15]. 
Primary prevention is therefore critical. This race group should no longer be 
regarded as a low risk group for ACS. 
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